|
Funded by a syndicate of well-respected, top-tier venture capital firms, Archemix has raised over $100 million to date. The Series B round ($53M, completed 1Q 2004) was led by Highland Capital Partners, and included all of the Series A investors and Athenian Venture Partners. The Series A round ($52M, completed 3Q 2002) included lead investors Atlas Venture, Prospect Venture Partners and SV Life Sciences. Other investors included Rho Ventures, Care Capital, MDS Capital, POSCO BioVentures, and US Trust Private Equity. Investors:
|
|
2008
